Investor · St. Louis, MO
Robert W. Karr
Open Robert in the network graph →Filings
24
SEC Form D
Connections
119
co-filers
Capital
$2.2M
across filings
Active
Jun 2012
to Oct 2015
Most-connected co-filers (119)
Pamela W. Manning · SAINT LOUIS, MO9 sharedJohn P. Mckearn · St. Louis, MO9 sharedCharles A. Bolten · St. Louis, MO9 sharedGregory N. Mossinghoff · RESEARCH TRIANGLE PARK, NC6 sharedGeorge H. Capps, Ii · St. Louis, MO6 sharedRichard Mott · Redwood City, CA6 sharedSeth Rudnick · MORRISVILLE, NC6 sharedHarold C. Nash · Luxembourg, Luxembourg6 sharedDaniel H. Weintraub · Boston, MA6 sharedJoseph Hardiman · Grand Cayman, Cayman Islands6 sharedDonald L. Dillingham · OKLAHOMA CITY, OK6 sharedRon A. Laufer · RESEARCH TRIANGLE PARK, NC6 sharedRajesh J. Devraj · St. Louis, MO6 sharedNavroop P. Mitter · McLean, VA6 sharedBrent Ahrens · Redwood City, CA6 sharedChristy Shaffer · Research Triangle Park, NC6 sharedMark A. Velleca · RESEARCH TRIANGLE PARK, NC6 sharedThomas P. Cirrito · St. Louis, MO4 sharedDavid W. Griggs · St. Louis, MO4 sharedGregg A. Jacobson · The Woodlands, TX4 sharedMichael W. Yeadon · St. Louis, MO4 sharedRobert Vaka · Atlanta, GA3 sharedBraddock Capital, LLC · Middleburg, VA3 sharedJeremy L. Neilson · Salt Lake City, UT3 shared
Recent filings (24)
Sharding Capital XII, a series of Sharding Capital Management, LLCApr 2019 · 7 co-filers$468KAngelList-MDI2-Fund, a series of AngelList-TF-Funds, LLCNov 2018 · 5 co-filers$507KAdjuvance Technologies Inc.Nov 2016 · 17 co-filers$7.0MTioma Therapeutics, Inc.Aug 2016 · 15 co-filers$86.3MTioma Therapeutics, Inc.Aug 2016 · 15 co-filers$86.3MWyndow, Inc.Jul 2016 · 13 co-filers$575KAntegrin Therapeutics, Inc.Oct 2015 · 19 co-filers$600KAntegrin Therapeutics, Inc.Oct 2015 · 19 co-filers$596KEuclises Pharmaceuticals, Inc.Oct 2015 · 18 co-filers$1.9MWyndow, Inc.Sep 2015 · 13 co-filers$2.0MAdjuvance Technologies Inc.Sep 2015 · 19 co-filers$7.0MVasculox, Inc.Aug 2015 · 16 co-filers$45.0MVasculox, Inc.Feb 2015 · 19 co-filers$2.8MAngelList-MDI2-Fund, a series of AngelList-TF-Funds, LLCOct 2014 · 5 co-filers$507KDISCOVERY LABORATORIES INC /DE/Oct 2014 · 26 co-filers$7.5MGIVING PLAN, LLCFeb 2014 · 3 co-filers$7.5MEuclises Pharmaceuticals, Inc.Jan 2014 · 16 co-filers$1.4MDISCOVERY LABORATORIES INC /DE/Dec 2013 · 14 co-filers$13.1MDISCOVERY LABORATORIES INC /DE/Sep 2013 · 14 co-filers$58KDISCOVERY LABORATORIES INC /DE/Jun 2013 · 14 co-filers$12KDISCOVERY LABORATORIES INC /DE/Mar 2013 · 14 co-filers$18KDISCOVERY LABORATORIES INC /DE/Feb 2013 · 14 co-filers$6.6MGIVING PLAN, LLCAug 2012 · 6 co-filers$7.5MG2G Holdings, LLCJun 2012 · 6 co-filers$7.5MTerpenoid Therapeutics, Inc.Jan 2010 · 4 co-filers$1.1M
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Robert in the interactive graph →